Melexis N.V.
MLXSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $4 | $3 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $4 | $3 | $4 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -3.3% | 15.3% | 29.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 43% | 45.7% | 44.8% | 42.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 28.5% | 31.6% | 32.3% | 29.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 18.4% | 21.7% | 23.6% | 20.4% |
| EPS Diluted | 4.24 | 5.18 | 4.88 | 3.25 |
| % Growth | -18.1% | 6.1% | 50.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | $0 |